Our data revealed that, despite their low density in tumor stroma, CD34_CAFs have a significant influence on LVI, PnI, NPI, G, recurrence, and survival in some of the most aggressive BC subtypes such as HER2 and TNBC. The gene discussed is ERBB2; the disease is breast cancer.